*GigaGen was acquired by Grifols in 2021 and continues to operate as a wholly owned subsidiary*Manage GigaGen's antibody therapeutics pipeline, overall R&D strategy, intellectual property, and budget- Invented, optimized, and implemented GigaGen's single cell technology platform that combines advanced molecular biology, microfluidics, next-generation sequencing, bioinformatics, protein engineering, and protein production to perform massively parallel single cell sequencing, expression, and functional screening of entire B cell (BCR) and T cell (TCR) repertoire libraries- Progressed four recombinant antibody therapeutics from discovery to clinical trials: anti-SARS-CoV-2 polyclonal [GIGA-2050], anti-HBV polyclonal [GIGA-2339], anti-CTLA-4 oncology mAb with unique MoA [GIGA-564], anti-VISTA oncology mAb [out-licensed]- Partnering with the U.S. Government's DoD and BARDA to develop antibodies against biothreats, starting with a recombinant anti-botulinum neurotoxin polyclonal therapeutic

GigaMune is developing technologies for in vivo delivery of T cell receptors (TCRs) and chimeric antigen receptors (CARs) for cancer and autoimmune diseases, with the goal of delivering any gene to any cell in any tissue location at any time

*LakePharma was acquired by Curia in 2021*- Managed and coordinated all internal and external protein/antibody therapeutic research projects- Served as scientific liaison between commercial team and research operations- Co-led (with CEO) business development efforts- Sought out then oversaw scientific collaborations with academic partners- Provided technical guidance for molecular biology and bioassays groups- Co-developed a novel monoclonal antibody sequence analysis tool

- Coordinated and performed large-scale RNA interference screen for colon cancer oncogenes- Characterized drug targetable pathways driving human colon cancer by combining bioinformatics and experimental methods

- Studied vertebrate transcription regulation using computational tools and mouse models in Gill Bejerano's laboratory (Department of Developmental Biology)